2001•Chinese HepatologyRequires access

Influences of vitamin E on the expression of tissue inhibitor of metalloproteinase-2, type III collagen and fibronectin in CCL_4-induced rats liver fibrosis.

Yuming Wang

Open publisher page 0 citations

Abstract

Objective To study the influences of vitamin E(VE) on liver fibrosis and its mechanism of action. Methods Liver fibrosis was induced in rats by the administration of CCL 4. The treatment group was treated with VE(100 mg/kg, IV) twice a week for 10 weeks after the liver fibrosis model was established. Immunohistochemical staining of hepatic type Ⅲ collagen protein and fibronectin were carried out in the 10th week after the administration of VE. At the same time, the hepatic contents of α 1(Ⅲ) procollagen and tissue inhibitor of metalloproteinase 2(TIMP 2)mRNA were observed with in situ hybridiznion. Results There were much less type Ⅲ collagen protein and fibronectin in the liver in the group treated with VE than that in the control. The expression of TIMP 2 and α 1(Ⅲ) procollagen mRNA were significantly inhibited in the treatment group. These changes were statistically significant as compared with that of the control group as examined by an image analysis system( P 0.05)。 Conclusion VE treatment can down modulate the expression of TIMP 2 mRNA in rats with liver fibrosis, thereby, play a role in the attenuation of fibrosis.

About this research paper

What this paper is about

Objective To study the influences of vitamin E(VE) on liver fibrosis and its mechanism of action. Methods Liver fibrosis was induced in rats by the administration of CCL 4. The treatment group was treated with VE(100 mg/kg, IV) twice a week for 10 weeks after the liver fibrosis model was established. Immunohistochemical staining of hepatic type Ⅲ collagen protein and fibronectin were carried out in the 10th week after the administration of VE. At the same time, the hepatic contents of α 1(Ⅲ) procollagen and tissue inhibitor of metalloproteinase 2(TIMP 2)mRNA were observed with in situ hybridiznion. Results There were much less type Ⅲ collagen protein and fibronectin in the liver in the group treated with VE than that in the control. The expression of TIMP 2 and α 1(Ⅲ) procollagen mRNA were significantly inhibited in the treatment group. These changes were statistically significant as compared with that of the control group as examined by an image analysis system( P 0.05)。 Conclusion VE treatment can down modulate the expression of TIMP 2 mRNA in rats with liver fibrosis, thereby, play a role in the attenuation of fibrosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the influences of vitamin E(VE) on liver fibrosis and its mechanism of action. Methods Liver fibrosis was induced in rats by the administration of CCL 4. The treatment group was treated with VE(100 mg/kg, IV) twice a week for 10 weeks after the liver fibrosis model was established. Immunohistochemical staining of hepatic type Ⅲ collagen protein and fibronectin were carried out in the 10th week after the administration of VE. At the same time, the hepatic contents of α 1(Ⅲ) procollagen and tissue inhibitor of metalloproteinase 2(TIMP 2)mRNA were observed with in situ hybridiznion. Results There were much less type Ⅲ collagen protein and fibronectin in the liver in the group treated with VE than that in the control. The expression of TIMP 2 and α 1(Ⅲ) procollagen mRNA were significantly inhibited in the treatment group. These changes were statistically significant as compared with that of the control group as examined by an image analysis system( P 0.05)。 Conclusion VE treatment can down modulate the expression of TIMP 2 mRNA in rats with liver fibrosis, thereby, play a role in the attenuation of fibrosis.

Key concepts: Procollagen peptidase, Fibronectin, Fibrosis, Immunohistochemistry, Hydroxyproline, Internal medicine, Tissue inhibitor of metalloproteinase, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Influences of vitamin E on the expression of tissue inhibitor of metalloproteinase-2, type III collagen and fibronectin in CCL_4-induced rats liver fibrosis. — Research Paper | ScholarLens